COYA 8-K: SEC filing
Filed with the SEC on · accession 0001193125-26-454473
COYA filed a 8-K (current report) with the SEC on Nov 10, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Summary of the filing
Coya Therapeutics furnished a press release disclosing its financial results of operations for the fiscal quarter ended September 30, 2026, under Item 2.02 of Form 8-K.
Key details
✦ Ask GOAX AI about this filing — what it means for COYA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for COYA?
Click hereFrequently asked questions
What did COYA file with the SEC on Nov 10, 2026?
COYA filed a 8-K (SEC filing). Coya Therapeutics furnished a press release disclosing its financial results of operations for the fiscal quarter ended September 30, 2026, under Item 2.02 of Form 8-K.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other COYA SEC filings
Get alerts when COYA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days